Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.07 | 0.7 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |